TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33019837

Group type: COMPARATOR
Intervention: Control group (n = 46)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Cervical shortening without funneling (n = 107)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: V‐shaped funneling (n = 68)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: U‐shaped funneling (n = 47)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Prolapse of the amniotic sac (n = 44)
Number of subjects: 312
Study: 32176574

Group type: EXPERIMENTAL
Intervention: Alcohol portrayals (yes)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Alcohol portrayals (no)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ego depletion (no)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ego depletion (yes)
Number of subjects: 90
Study: 35279508

Group type: EXPERIMENTAL
Intervention: SLN biopsy only
Number of subjects: 1181

Group type: COMPARATOR
Intervention: Completion ALND
Number of subjects: 1181
Study: 32230721

Group type: EXPERIMENTAL
Intervention: Robuvit® (300 mg/day) for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Robuvit®
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33399514

Group type: EXPERIMENTAL
Intervention: Active Laryngeal Force Sensor (LFS) monitoring
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no active LFS monitoring)
Number of subjects: 200
Study: 32375613

Group type: EXPERIMENTAL
Intervention: Bisoprolol (VCR-reducing therapy)
Number of subjects: 75
Study: 36175977

Group type: EXPERIMENTAL
Intervention: Integrated mental health care and vocational rehabilitation (IBBIS-II)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Service as usual (SAU)
Number of subjects: 900
Study: 34235560

Group type: EXPERIMENTAL
Intervention: Eluvia DES
Number of subjects: 84

Group type: COMPARATOR
Intervention: Zilver PTX drug-coated stent
Number of subjects: 84
Study: 32102239

Group type: EXPERIMENTAL
Intervention: MCA stroke participants
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (25 neurotypical adult males)
Number of subjects: 7
Study: 36208795

Group type: EXPERIMENTAL
Intervention: Computer-assisted detection (CADe)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Conventional colonoscopy
Number of subjects: 223
Study: 34671454

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32921388

Group type: EXPERIMENTAL
Intervention: Various interventions for OLP treatment (specific interventions not detailed in the abstract)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Clinical symptom assessment
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Clinical score assessment
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Visual analog scale
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Thongprasom scoring system
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Oral health-related quality of life measures
Number of subjects: 88
Study: 35963234

Group type: EXPERIMENTAL
Intervention: Vaccination strategies for recovered inpatients with COVID-19
Number of subjects: 0
Study: 33417279

Group type: EXPERIMENTAL
Intervention: 1‐IOD (single midline implant)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 2‐IOD (two implants in the canine regions bilaterally)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 1‐IOD
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 2‐IOD
Number of subjects: 47
Study: 32861144

Group type: EXPERIMENTAL
Intervention: HAART treatment for 48 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HAART treatment for 48 weeks in low microbial translocation (MT) group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HAART treatment for 48 weeks in high microbial translocation (MT) group
Number of subjects: 0
Study: 33300437

Group type: EXPERIMENTAL
Intervention: Individualized antiplatelet therapy based on CYP2C19 genotyping (IA group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional antiplatelet therapy (CA group)
Number of subjects: 0
Study: 34680732

Group type: EXPERIMENTAL
Intervention: Arm I (data-based feedback and quality circles)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Arm II (data-based feedback, quality circles, and additional components)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Arm III (data-based feedback, quality circles, and different additional components)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: All intervention arms (I, II, III)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Matched standard care
Number of subjects: 196
Study: 33608465

Group type: EXPERIMENTAL
Intervention: E-cigarette use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: E-cigarette use among 15-24 years age group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: E-cigarette use and smoking cessation
Number of subjects: 0
Study: 35513910

Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic (Vivomixx®) 4.4 g/day for 4 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: Non-probiotic milk-powder placebo 4.4 g/day for 4 weeks
Number of subjects: 59
Study: 33213193

Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 616533255

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (15°C for 5 minutes)
Number of subjects: 20
Study: 34550476

Group type: EXPERIMENTAL
Intervention: Single-incision approach
Number of subjects: 40

Group type: COMPARATOR
Intervention: Double-incision approach
Number of subjects: 40
Study: 32761373

Group type: EXPERIMENTAL
Intervention: One anastomosis gastric bypass (OAGB)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both OAGB and RYGB
Number of subjects: 33
Study: 33890158

Group type: COMPARATOR
Intervention: Concurrent training (PAR)
Number of subjects: 67
Study: 35938554

Group type: EXPERIMENTAL
Intervention: Hughes abdominal closure
Number of subjects: 802

Group type: COMPARATOR
Intervention: Standard mass closure
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Computed tomography scanning
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 802
Study: 33070947

Group type: EXPERIMENTAL
Intervention: IMPACT-Core model
Number of subjects: 26228

Group type: EXPERIMENTAL
Intervention: CRASH-Basic model
Number of subjects: 26228

Group type: EXPERIMENTAL
Intervention: Both models
Number of subjects: 26228
Study: 36399673

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg once daily for three weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Enoxaparin 40 mg once daily for three weeks
Number of subjects: 120
Study: 32325265

Group type: EXPERIMENTAL
Intervention: Centrifugation + 1-day inoculation
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Centrifugation + 14-day inoculation
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Stationary inoculation + 1-day
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Stationary inoculation + 14-day
Number of subjects: 44
Study: 34046741

Group type: EXPERIMENTAL
Intervention: Genetic liability to periodontitis (measured using six SNPs associated with periodontitis)
Number of subjects: 17353

Group type: EXPERIMENTAL
Intervention: Replication analysis using genetic instruments from two different GWAS
Number of subjects: 17353
Study: 32027842

Group type: EXPERIMENTAL
Intervention: m102.4 (1 mg/kg, 3 mg/kg, 10 mg/kg, 20 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: m102.4 (20 mg/kg, two infusions 72 hours apart)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: m102.4
Number of subjects: 40
Study: 35477745

Group type: EXPERIMENTAL
Intervention: tsDCS + LT
Number of subjects: 8

Group type: COMPARATOR
Intervention: sham + LT
Number of subjects: 8
Study: 33326481

Group type: EXPERIMENTAL
Intervention: Observational learning with a model introduced as another participant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational learning with a model introduced as a coworker of the experimenter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with no observation
Number of subjects: 0
Study: 32159592

Group type: EXPERIMENTAL
Intervention: Symptomatic patients (moderate and severe)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Asymptomatic patients
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Mild symptomatic patients
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Contiguous symptomatic subgroups
Number of subjects: 135
Study: 34486653

Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 1988

Group type: COMPARATOR
Intervention: CRT-P
Number of subjects: 1988
Study: 32924183

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) training for PHNs
Number of subjects: 6
Study: 35149322

Group type: EXPERIMENTAL
Intervention: Patients with prescription OUD
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 36
Study: 32828931

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CTx)
Number of subjects: 249
Study: 35059838

Group type: EXPERIMENTAL
Intervention: Robotic surgery
Number of subjects: 362

Group type: COMPARATOR
Intervention: Laparoscopic surgery
Number of subjects: 362
Study: 33858369

Group type: EXPERIMENTAL
Intervention: Reduction of immunosuppression after diagnosis of HuNoV infection; 93% of cases experienced this intervention.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: HuNoV infection; cases vs controls
Number of subjects: 72
Study: 32717421

Group type: EXPERIMENTAL
Intervention: Circulating miR‐21 levels in DCM group
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: miR‐21 combined with duration of diabetes, HbA1c%, and lipid profiles
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Overexpression of miR‐21
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Inhibition of miR‐21
Number of subjects: 266
Study: 36175576

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ; 12.8 mmol NO3‐)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 10
Study: 33517703

Group type: EXPERIMENTAL
Intervention: Elevated serum complement C3 levels
Number of subjects: 3474

Group type: EXPERIMENTAL
Intervention: Each SD increase of log-transformed complement C3
Number of subjects: 3474

Group type: EXPERIMENTAL
Intervention: Addition of serum complement C3 to conventional risk factors
Number of subjects: 3474
Study: 32487157

Group type: EXPERIMENTAL
Intervention: Stop-Tabac smartphone application
Number of subjects: 5200
Study: 32706921

Group type: EXPERIMENTAL
Intervention: Generic metformin ER tablets
Number of subjects: 4

Group type: COMPARATOR
Intervention: Branded metformin ER tablets
Number of subjects: 4
Study: 34895119

Group type: EXPERIMENTAL
Intervention: Folic acid treatment (5 mg daily for 3 months)
Number of subjects: 113

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 113
Study: 32500344

Group type: EXPERIMENTAL
Intervention: Adjuvant transcatheter arterial infusion therapy (TAI)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Hepatectomy alone (Control)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Adjuvant TAI for lower-cholinesterase patients
Number of subjects: 114
Study: 36190577

Group type: EXPERIMENTAL
Intervention: Dietary intervention with two healthy dietary approaches
Number of subjects: 0
Study: 34078808

Group type: EXPERIMENTAL
Intervention: Limited-point plasma concentration analysis of CYP substrates in a cocktail drug
Number of subjects: 0
Study: 33154071

Group type: EXPERIMENTAL
Intervention: Total NAA (tNAA)/total Cr (tCr) in normal-appearing WM
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Total NAA (tNAA) and tNAA/tCr in normal-appearing WM
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: mIns/tCr in normal-appearing WM
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Total Cho (tCho) in GM
Number of subjects: 119
Study: 34014046

Group type: EXPERIMENTAL
Intervention: Average volume-assured pressure support (AVAPS) mode
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bilevel positive airway pressure-spontaneous/timed (BPAP-S/T) mode
Number of subjects: 60
Study: 36333015

Group type: EXPERIMENTAL
Intervention: AI‐ECG algorithm notification
Number of subjects: 11573

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 11573
Study: 32964377

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy
Number of subjects: 0
Study: 33909659

Group type: EXPERIMENTAL
Intervention: PBM + STRONTIUM (10% strontium chloride + PBM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo + PBM
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: STRONTIUM (10% strontium chloride)
Number of subjects: 50

Group type: COMPARATOR
Intervention: PLACEBO (placebo gel + simulation of PBM)
Number of subjects: 50
Study: 32267191

Group type: EXPERIMENTAL
Intervention: Oncology subspecialty trials
Number of subjects: 1340

Group type: EXPERIMENTAL
Intervention: Infertility/andrology subspecialty trials
Number of subjects: 1340

Group type: EXPERIMENTAL
Intervention: Device trials
Number of subjects: 1340

Group type: EXPERIMENTAL
Intervention: Combination funding by industry/government/grants
Number of subjects: 1340

Group type: COMPARATOR
Intervention: Clinical trials in AUA sections
Number of subjects: 1340

Group type: COMPARATOR
Intervention: Failed trials
Number of subjects: 1340
Study: 616627663

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34315331

Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 263

Group type: COMPARATOR
Intervention: Adalimumab, Secukinumab, Guselkumab, Ixekizumab, Brodalumab
Number of subjects: 263
Study: 35982449

Group type: COMPARATOR
Intervention: Margarine without TFA (wTFA control group with 0.4 g TFA per 100 g margarine)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Margarine with iTFA (iTFA group with 4.1 g TFA per 100 g margarine)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Butter with rTFA (rTFA group with 6.3 g TFA per 100 g butter)
Number of subjects: 42
Study: 32702252

Group type: EXPERIMENTAL
Intervention: HEA-enriched Cordyceps cicadae mycelium (1.05 g granules once a day for 3 months)
Number of subjects: 49
Study: 35372614

Group type: EXPERIMENTAL
Intervention: Sexual health counseling based on cognitive-behavioral therapy (CBT), 8 sessions of 90 minutes each
Number of subjects: 52

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 52
Study: 34029707

Group type: EXPERIMENTAL
Intervention: Extended infusion (EI) of piperacillin/tazobactam (PTZ) at 100 mg/kg intravenously every 8 h for 4 hours
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intermittent bolus (IB) of piperacillin/tazobactam (PTZ) at 100 mg/kg intravenously every 8 h for 30 minutes
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Extended infusion (EI)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intermittent bolus (IB)
Number of subjects: 90
Study: 32574418

Group type: EXPERIMENTAL
Intervention: Terlipressin and Albumin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33227175

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32441811

Group type: EXPERIMENTAL
Intervention: Swanson's Care
Number of subjects: 104
Study: 34254966

Group type: EXPERIMENTAL
Intervention: Sensory Adaptation Training (SAT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 49
Study: 36293765

Group type: EXPERIMENTAL
Intervention: FIFA 11+ intervention for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 20
Study: 33858620

Group type: EXPERIMENTAL
Intervention: Tocilizumab (280 mg single infusion)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 33784350

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32731960

Group type: EXPERIMENTAL
Intervention: Cryotherapy with mobilization (CM) twice per week for 5 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cryotherapy with mobilization plus home stretching exercises (CMS) 5 times per week for 5 weeks
Number of subjects: 60
Study: 34059149

Group type: EXPERIMENTAL
Intervention: Newly derived spot urine equation
Number of subjects: 768

Group type: COMPARATOR
Intervention: Tanaka equation
Number of subjects: 768

Group type: COMPARATOR
Intervention: INTERSALT equation
Number of subjects: 768
Study: 32059083

Group type: EXPERIMENTAL
Intervention: Everolimus (EVR)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Calcineurin inhibitor (CNI)
Number of subjects: 90
Study: 32964331

Group type: EXPERIMENTAL
Intervention: Home video recording by family members for remote assessment of ataxia severity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remote assessments of ataxia severity
Number of subjects: 0
Study: 35946269

Group type: EXPERIMENTAL
Intervention: Spiritual therapy (spiritual chanting and listening)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no spiritual intervention)
Number of subjects: 100
Study: 33008422

Group type: EXPERIMENTAL
Intervention: Incidental irradiation of axillary nodes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intentional irradiation (breast, tumor bed, axillary and supraclavicular lymph node areas)
Number of subjects: 0
Study: 35619162

Group type: EXPERIMENTAL
Intervention: Suprapatellar nailing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Infrapatellar nailing
Number of subjects: 60
Study: 32046656

Group type: EXPERIMENTAL
Intervention: Stratified care using the Keele STarT MSK development tool for risk-stratification and matched treatment options for low-, medium-, and high-risk patients.
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Stratified care using the Keele STarT MSK development tool.
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Stratified care using matched treatment options.
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Stratified care using the Keele STarT MSK tool and matched treatment options.
Number of subjects: 524

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 524
Study: 36468569

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg daily for 2 weeks)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Diclofenac (50 mg three times daily for 2 weeks)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Co-administration of omeprazole and diclofenac (for 2 weeks)
Number of subjects: 32
Study: 33629897

Group type: EXPERIMENTAL
Intervention: Detomidine (DET), 0.015 to 0.02 mg/kg, IV
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfadiazine (TMS), 16 to 24 mg/kg, IV
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: TMS plus DET
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline (0.9% NaCl) solution
Number of subjects: 9
Study: 616862284

Group type: EXPERIMENTAL
Intervention: Vitamin D replacement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34543523

Group type: EXPERIMENTAL
Intervention: Femtosecond laser (FSL)‐assisted cataract surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual cataract surgery
Number of subjects: 60
Study: 33407781

Group type: EXPERIMENTAL
Intervention: Personalised approach bias modification (ABM) training, 6 sessions, using personalised methamphetamine images as avoidance and positive images as approach.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham training (control condition).
Number of subjects: 100
Study: 35865736

Group type: EXPERIMENTAL
Intervention: NT380-Mini
Number of subjects: 927

Group type: COMPARATOR
Intervention: TCu380A
Number of subjects: 927
Study: 32675390

Group type: EXPERIMENTAL
Intervention: Lumbar stabilization and thoracic mobilization exercise program in a closed kinetic chain (LSTMC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Lumbar stabilization exercise program in a closed kinetic chain (LSCO)
Number of subjects: 80
Study: 34887544

Group type: EXPERIMENTAL
Intervention: Behavioural activation SSI
Number of subjects: 2452

Group type: EXPERIMENTAL
Intervention: SSI teaching that traits are malleable
Number of subjects: 2452

Group type: COMPARATOR
Intervention: Supportive control
Number of subjects: 2452
Study: 34057698

Group type: EXPERIMENTAL
Intervention: CPP-ACP cream (daily single application)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fluoride varnish (professional application every 3 months)
Number of subjects: 30
Study: 33245970

Group type: EXPERIMENTAL
Intervention: Guided endodontics
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional access technique
Number of subjects: 30
Study: 36192774

Group type: EXPERIMENTAL
Intervention: Proactive community case management (pro‐CCM)
Number of subjects: 27087

Group type: COMPARATOR
Intervention: Conventional integrated community case management (iCCM)
Number of subjects: 27087
Study: 34122682

Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg/day) and Vitamin E (800 IU/day) combination
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vitamin C and Vitamin E combination
Number of subjects: 60
Study: 32320637

Group type: EXPERIMENTAL
Intervention: Dibutyl Phthalate (DBP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control Air
Number of subjects: 16
Study: 35759255

Group type: EXPERIMENTAL
Intervention: N95 mask
Number of subjects: 24

Group type: COMPARATOR
Intervention: Surgical mask
Number of subjects: 24
Study: 32489082

Group type: EXPERIMENTAL
Intervention: Oral Chinese medicine
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Oral Chinese medicine (tablets and granules)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Oral Chinese medicine (decoction and oral liquids)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Combination of oral Chinese medicine and Western medicine
Number of subjects: 218
Study: 36201354

Group type: EXPERIMENTAL
Intervention: ATI-2173 10 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: ATI-2173 25 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: ATI-2173 50 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: ATI-2173
Number of subjects: 13